Target intelligence / Profile preview

Cellular membranes and surface receptors of recipient cells

Molecular classification
Other, Receptor
01

Overview

Cellular membranes and surface receptors of recipient cells refers to the biological interface consisting of the phospholipid bilayer and embedded proteins that define the boundary of a target cell. This complex structure is responsible for maintaining cellular integrity, regulating the transport of ions and molecules, and facilitating communication between the cell and its environment (Alberts et al., 2002). In the context of intercellular communication, these membranes and receptors serve as the primary docking sites for extracellular vesicles (EVs) and viruses, which utilize specific surface proteins to initiate uptake or fusion (Mulcahy et al., 2014). In pharmacology, this interface is the primary site for drug-target interactions, where surface receptors like G protein-coupled receptors (GPCRs) or ion channels serve as docking sites for therapeutic ligands (Conner & Schmid, 2003). Furthermore, the recipient cell membrane is a critical barrier for the delivery of advanced therapies, including mRNA-loaded lipid nanoparticles, which must navigate endocytic pathways to reach their intracellular destinations (Sahay et al., 2010). The specific composition of receptors and lipids on these membranes often dictates the tissue specificity and efficacy of a drug, making them central to the design of targeted delivery systems (Behzadi et al., 2017). However, because this term describes a broad anatomical location rather than a specific molecular entity, it is considered a general biological category rather than a single therapeutic target.

Other names
Cell surfacePlasma membraneTarget cell receptorsRecipient cell interface
02

Mechanism of action

Drugs and delivery vehicles interact with this site by binding to specific surface proteins to modulate signaling or by interacting with the lipid bilayer to facilitate cellular entry via endocytosis or membrane fusion (Conner & Schmid, 2003; Sahay et al., 2010).

03

Biological functions

Signal transductionCellular entryEndocytosisCell-cell communication
04

Disease associations

InfectionCancerGenetic diseases
05

Safety considerations

Off-target bindingMembrane disruptionImmunogenicity of delivery vehiclesSystemic toxicity
06

Interacting drugs

Maraviroc

3 more in the full profile.

07

Biomarkers

CD markersReceptor expression levelsMembrane lipid composition

Beyond the preview

Go deeper on Cellular membranes and surface receptors of recipient cells.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Cellular membranes and surface receptors of recipient cells.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call